This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (96)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Dementias  • Alert me on articles by topic  Social Bookmarking   What's this?

Julene K. Johnson, PhD; Elizabeth Head, PhD; Ronald Kim, MD; Arnold Starr, MD; Carl W. Cotman, PhD

Arch Neurol. 1999;56:1233-1239.

Objective  To evaluate the clinical and pathological features of a subgroup of patients with Alzheimer disease (AD) who exhibited early and disproportionately severe impairments on tests of frontal lobe functioning. We hypothesized that these patients would exhibit a greater degree of either neurofibrillary tangle (NFT) or senile plaque pathology in the frontal lobes than would patients with typical AD.

Design and Outcome Measures  We examined the neuropsychological profiles and senile plaque and NFT accumulation in the frontal, entorhinal, temporal, and parietal cortices in 3 patients with AD who exhibited disproportionate frontal impairments during early stages of dementia (frontal AD) and 3 matched patients with typical AD (typical AD).

Results  Compared with the typical AD group, the frontal AD group performed significantly worse on 2 tests of frontal lobe functioning and on the Wechsler Adult Intelligence Scale–Revised Block Design test. No significant group differences were found on other tests. Analysis of brain tissue samples demonstrated that, despite comparable entorhinal, temporal, and parietal NFT loads, the frontal AD group showed a significantly higher NFT load in the frontal cortex than the typical AD group. Senile plaque pathology in the frontal and entorhinal cortices did not differentiate the 2 groups.

Conclusions  We identified a subgroup of patients with pathologically confirmed AD who presented in the early stages of dementia with disproportionate impairments on tests of frontal lobe functioning and had a greater-than-expected degree of NFT pathology in the frontal lobes, suggesting the existence of a frontal variant of AD that has distinctive clinical and pathological features.

From the Institute for Brain Aging and Dementia, University of California at Irvine.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(10):1302-1303.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Picture of a Patient With a Novel PSEN1 Mutation (L424V)
Robles et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2009;24:40-45.
ABSTRACT  

Alzheimer Abnormalities of the Amygdala With Kluver-Bucy Syndrome Symptoms: An Amygdaloid Variant of Alzheimer Disease
Kile et al.
Arch Neurol 2009;66:125-129.
ABSTRACT | FULL TEXT  

Executive Function and Gait in Older Adults With Cognitive Impairment
Persad et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2008;63:1350-1355.
ABSTRACT | FULL TEXT  

Longitudinal decline in autopsy-defined frontotemporal lobar degeneration
Grossman et al.
Neurology 2008;70:2036-2045.
ABSTRACT | FULL TEXT  

CSF biomarkers in frontotemporal lobar degeneration with known pathology
Bian et al.
Neurology 2008;70:1827-1835.
ABSTRACT | FULL TEXT  

Patient Care and Management of Frontotemporal Lobar Degeneration
Massimo and Grossman
AM J ALZHEIMERS DIS OTHER DEMEN 2008;23:125-131.
ABSTRACT  

Distinct Antemortem Profiles in Patients With Pathologically Defined Frontotemporal Dementia
Grossman et al.
Arch Neurol 2007;64:1601-1609.
ABSTRACT | FULL TEXT  

Focal cortical presentations of Alzheimer's disease
Alladi et al.
Brain 2007;130:2636-2645.
ABSTRACT | FULL TEXT  

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Foster et al.
Brain 2007;130:2616-2635.
ABSTRACT | FULL TEXT  

Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration
Pijnenburg et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:735-737.
ABSTRACT | FULL TEXT  

Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study
Boeve et al.
Brain 2006;129:3103-3114.
ABSTRACT | FULL TEXT  

Measurements of the Amygdala and Hippocampus in Pathologically Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration.
Barnes et al.
Arch Neurol 2006;63:1434-1439.
ABSTRACT | FULL TEXT  

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.
Cummings et al.
Neurology 2006;67:57-63.
ABSTRACT | FULL TEXT  

Neuropsychological function in nondemented carriers of presenilin-1 mutations
Ringman et al.
Neurology 2005;65:552-558.
ABSTRACT | FULL TEXT  

Subcortical vascular dementia: Integrating neuropsychological and neuroradiologic data
Price et al.
Neurology 2005;65:376-382.
ABSTRACT | FULL TEXT  

Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients
Kim et al.
Brain 2005;128:1790-1801.
ABSTRACT | FULL TEXT  

Frontotemporal Lobar Degeneration: Demographic Characteristics of 353 Patients
Johnson et al.
Arch Neurol 2005;62:925-930.
ABSTRACT | FULL TEXT  

Diffusion Tensor Imaging of Frontal White Matter Microstructure in Early Alzheimer's Disease: A Preliminary Study
Choi et al.
J Geriatr Psychiatry Neurol 2005;18:12-19.
ABSTRACT  

Executive Dysfunction in Alzheimer Disease
Swanberg et al.
Arch Neurol 2004;61:556-560.
ABSTRACT | FULL TEXT  

Focal right inferotemporal atrophy in AD with disproportionate visual constructive impairment
Boxer et al.
Neurology 2003;61:1485-1491.
ABSTRACT | FULL TEXT  

Very early onset AD with a de novo mutation in the presenilin 1 gene (Met 233 Leu)
Portet et al.
Neurology 2003;61:1136-1137.
ABSTRACT | FULL TEXT  

Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia
Knopman et al.
Mayo Clin Proc. 2003;78:1290-1308.
ABSTRACT  

Presenile dementia syndromes: an update on taxonomy and diagnosis
Greicius et al.
J. Neurol. Neurosurg. Psychiatry 2002;72:691-700.
ABSTRACT | FULL TEXT  

Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia
Rinne et al.
Neurology 2002;58:1489-1493.
ABSTRACT | FULL TEXT  

Semantic dementia versus Alzheimer's disease: A matter of semantics?
Morris and Balota
Neurology 2001;57:173-174.
FULL TEXT  

Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia
Galton et al.
Neurology 2001;57:216-225.
ABSTRACT | FULL TEXT  

Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Knopman et al.
Neurology 2001;56:1143-1153.
ABSTRACT | FULL TEXT  

Correlation between Caspase Activation and Neurofibrillary Tangle Formation in Alzheimer's Disease
Rohn et al.
Am. J. Pathol. 2001;158:189-198.
ABSTRACT | FULL TEXT  

Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I
Lopez et al.
Neurology 2000;55:1854-1862.
ABSTRACT | FULL TEXT  

Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation
Raux et al.
Neurology 2000;55:1577-1579.
ABSTRACT | FULL TEXT  

Topography, Histology, and Seminology in Dementia
Caselli et al.
Arch Neurol 2000;57:899-900.
FULL TEXT